Results 131 to 140 of about 5,357,473 (408)

Cervical Cancer-Associated Human Papillomavirus 16 E7 Oncoprotein Inhibits Induction of Anti-Cancer Immunity by a CD4+ T Cell Dependent Mechanism [PDF]

open access: yes, 2009
Attempts to develop therapeutic vaccines against cervical cancer have been proven difficult. One of the major causes of the failure is due to the use of the wrong mouse models based on transplantable tumours in testing the efficacy of vaccines.
Germain J. Fernando   +3 more
core   +2 more sources

The causal relation between human papillomavirus and cervical cancer.

open access: yesJournal of Clinical Pathology, 2002
The causal role of human papillomavirus infections in cervical cancer has been documented beyond reasonable doubt. The association is present in virtually all cervical cancer cases worldwide.
F. Bosch   +4 more
semanticscholar   +1 more source

World Health Organization call for action to eliminate cervical cancer globally

open access: yesInternational Journal of Gynecological Cancer, 2020
Cervical cancer is the fourth most common cancer among women globally, with an estimated 570 000 new cases and 311 000 deaths worldwide in 2018.[1–3][1] The highest regional incidence and mortality rates are seen in Africa, where the rates are 7–10 times
M. Gultekin   +3 more
semanticscholar   +1 more source

Possible role of human ribonuclease dicer in the regulation of R loops

open access: yesFEBS Open Bio, EarlyView.
R loops play an important role in regulating key cellular processes such as replication, transcription, centromere stabilization, or control of telomere length. However, the unscheduled accumulation of R loops can cause many diseases, including cancer, and neurodegenerative or inflammatory disorders. Interestingly, accumulating data indicate a possible
Klaudia Wojcik   +2 more
wiley   +1 more source

CNN-based Approach for Cervical Cancer Classification in Whole-Slide Histopathology Images [PDF]

open access: yesarXiv, 2020
Cervical cancer will cause 460 000 deaths per year by 2040, approximately 90% are Sub-Saharan African women. A constantly increasing incidence in Africa making cervical cancer a priority by the World Health Organization (WHO) in terms of screening, diagnosis, and treatment.
arxiv  

Computer-Aided Detection of Pathologically Enlarged Lymph Nodes On Non-Contrast CT In Cervical Cancer Patients For Low-Resource Settings [PDF]

open access: yes, 2017
The mortality rate of cervical cancer is approximately 266,000 people each year, and 70% of the burden occurs in Low- and Middle- Income Countries (LMICs). Radiation therapy is the primary modality for treatment of locally advanced cervical cancer cases.
Anderson, Brian M   +7 more
core   +1 more source

Knowledge, attitude and practice about cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of Congo [PDF]

open access: yes, 2014
Background: Cervical cancer is the most frequent cancer of women in the Democratic Republic of Congo (DRC). Nevertheless, the level of women's awareness about cervical cancer is unknown.
Ali-Risasi, Catherine   +4 more
core   +2 more sources

Multiclass Classification of Cervical Cancer Tissues by Hidden Markov Model [PDF]

open access: yesarXiv, 2015
In this paper, we report a hidden Markov model based multiclass classification of cervical cancer tissues. This model has been validated directly over time series generated by the medium refractive index fluctuations extracted from differential interference contrast images of healthy and different stages of cancer tissues.
arxiv  

CERVIS: Cervical Cancer Early Response Visual Identification System [PDF]

open access: yes, 2019
The goal of CERVIS is to make a substantial, positive impact in the cervical cancer screening space through the development of a minimally invasive, cost effective solution that enables women in low-resource settings to test for cervical cancer on a ...
Hultquist, Claire   +3 more
core   +1 more source

A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients

open access: yesFrontiers in Oncology, 2020
It has been confirmed that the systemic inflammation response index (SIRI) based on peripheral blood neutrophil, monocyte and lymphocyte counts can be used for the prognostication of patients with various malignant tumors.
Bei Chao   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy